Pre-made Vantictumab benchmark antibody ( Whole mAb, anti-FZD Family therapeutic antibody) for drug discovery and mechanism of action (MOA) research
Cat No.: GMP-Bios-ab-611
Pre-Made Vantictumab biosimilar, Whole Mab: Anti-FZD Family therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Vantictumab is a human IgG2 monoclonal antibody designed for the treatment of cancer.
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Pre-Made Vantictumab biosimilar, Whole Mab: Anti-FZD Family therapeutic antibody|
|Highest_Clin_Trial (Jan '20)||Phase-I|
|100% SI Structure||None|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Companies||Bayer HealthCare Pharmaceuticals;OncoMed Pharmaceuticals|
|Conditions Discontinued||Breast cancer;Non-small cell lung cancer;Pancreatic cancer|
|Development Tech||MorphoSys HuCAL Phage Display|